The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)

Natural killer (NK) cells have played a critical—if largely unrecognized or ignored—role in the treatment of B cell non-Hodgkin lymphoma (NHL) since the introduction of CD20-directed immunotherapy with rituximab as a cornerstone of therapy over 25 years ago. Engagement with NK cells leading to lysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Yaya, Lamb, Margaret, Cairo, Mitchell S., Lee, Dean A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Lymphoma (JL Muñoz, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930876/
https://www.ncbi.nlm.nih.gov/pubmed/35258793
http://dx.doi.org/10.1007/s11864-021-00932-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930876/
https://www.ncbi.nlm.nih.gov/pubmed/35258793
http://dx.doi.org/10.1007/s11864-021-00932-2

Ejemplares similares